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Differentiation of murine embryonic stem cells to thyrocytes 
requires insulin and insulin-like growth factor-1 
Maria C. Arufe, Min Lu, Reigh-Yi Lin 
Abstract 
The mechanisms controlling thyrocyte development during embryonic stem (ES) cell differentiation have only been 
partially elucidated, although previous studies have suggested the participation of thyroid stimulating hormone (TSH) 
in these processes. To further define the role of TSH in this context, we have studied a murine ES cell line in which 
green fluorescent protein (GFP) cDNA is targeted to the TSH receptor (TSHR) gene, linking the expression of GFP 
to the transcription of the endogenous TSHR gene. We demonstrate that, in the initial stages of embryoid body 
formation, activin A and TSH induce the differentiation of definitive endoderm and thyrocyte progenitors expressing 
Sox17, Foxa2, and TSHR. These thyrocyte progenitors are then converted into cellular aggregates that, in the 
presence of insulin and IGF-1, further differentiate into mature thyroglobulin-expressing thyrocytes. Our data suggest 
that, despite the fact that TSH is important for the induction and specification of thyrocytes from ES cells, insulin and 
IGF-1 are crucial for thyrocyte maturation. Our method provides a powerful in vitro differentiation model for 
studying the mechanisms of early thyrocyte lineage development. 
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Introduction 
Embryonic stem (ES) cells, isolated from the inner cell mass of developing blastocysts, have the ability to 
proliferate indefinitely in culture and to generate all cell types in the body [1]. These properties make ES 
cells not only a novel and unlimited source of cells for the treatment of a broad spectrum of diseases, but 
also an ideal model of early embryonic development. Among the cell types that can be generated from ES 
cells, thyrocytes are of particular interest since they are the only cells in the body that can absorb iodine 
and convert it into the thyroid hormones required for metabolic homeostasis, growth and development. 
Thyroid organogenesis is a complex and highly regulated process controlled by various key transcription 
factors, growth factors and hormones. Elucidating the molecular mechanisms of thyroid development 
during ES cell differentiation could aid in the understanding of how biological processes malfunction and 
lead to human disease. 
More than 70% of the thyroid gland is composed of thyrocytes arranged in follicles. The thyrocyte 
lineage is one of the least recognizable cell types in a culture of differentiating ES cells. Unlike 
cardiovascular lineage cells that exhibit characteristic spontaneous, rhythmic contractions, identification 
of the thyrocyte lineage by conventional differentiation screens is challenging. Our laboratory was the 
first to demonstrate that mouse CCE ES cells can differentiate into thyrocyte-like cells when cultured 
with thyroid stimulating hormone (TSH), the major regulator of the thyroid gland [2] and [3]. The effect 
of TSH on the thyroid gland is mediated by its interaction with a G protein-coupled glycoprotein receptor, 
TSHR, and activation of the cAMP-adenylate cyclase pathway. In previous studies, we analyzed 
thyrocyte progenitors in embryoid bodies (EBs) differentiated from ES cells in which the expression of 
green fluorescent protein (GFP) had been linked to the transcription of the endogenous TSHR gene. We 
demonstrated that these early EBs contained a subpopulation of TSHR-expressing cells that can 
differentiate into thyrocyte-like cells upon additional culture with TSH [4]. However, we were unable to 
detect the expression of thyroglobulin (Tg; a key terminal marker and the precursor of thyroid hormones) 
in these cells. These observations suggest that TSH alone is not sufficient to maintain the thyrocyte 
phenotype over time and imply that other factors must control the maturation of thyrocytes in ES cell 
differentiation cultures.  
Thyrocytes are derived from the definitive endodermal germ layer, and recent work by Kubo et al. and 
others demonstrated that a brief challenge of activin A, a member of the TGFβ family, during early 
differentiation can enhance the formation of definitive endoderm in mouse and human ES cells [5], [6], 
[7] and [8]. In this report, we describe a reliable and simple way to use activin A, TSH, and other 
maturation factors in serum-free medium to induce mouse ES cells to differentiate into mature Tg-
expressing thyrocytes. We provide evidence that, despite the fact that TSH is important for the induction 
and specification of thyrocytes from ES cells, insulin and insulin-like growth factor-1 (IGF-1) are crucial 
for thyrocyte maturation. 
Materials and methods 
Growth and maintenance of ES cell culture. The development of the TSHR+/− ES cell line has been 
reported [4] and [9]. The undifferentiated TSHR+/− ES cell line was maintained on an irradiated mouse 
embryonic fibroblast feeder layer in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, 
CA) supplemented with 15% fetal calf serum (FCS), penicillin–streptomycin (100 U/ml, Invitrogen), 
10 ng/ml leukemia inhibitory factor (LIF, StemCell Technologies, Vancouver, Canada), and 1.5 × 10−4 M 
monothioglycerol (MTG, Sigma–Aldrich, St. Louis). Cultures were maintained in a humidified chamber 
in a 5% CO2/air mixture at 37 °C. 
 
In vitro differentiation of thyrocytes from ES cells. Differentiation was carried out as shown in Fig. 1. To 
induce the formation of EBs, ES cells were trypsinized into a single-cell suspension and plated at varying 
densities (103–105 cells/ml) in 60-mm Petri-grade dishes in EB differentiation medium (EBDM) 
containing Iscove’s modified Dulbecco’s medium (IMDM; Invitrogen) supplemented with 
penicillin/streptomycin, 15% FCS, 2 mM l-glutamine, 5% protein-free hybridoma medium (Invitrogen), 
0.5 mM ascorbic acid and 1.5 × 10−4 M MTG. For endoderm differentiation, the EBs were harvested at 
day 2 of differentiation and cultured in IMDM supplemented with 15% KnockOut serum replacement 
medium (KSR, Invitrogen), penicillin/streptomycin, 0.5 mM ascorbic acid, 1.5×10−4 M MTG and 10 ng 
human recombinant activin A (R&D Systems, Inc., Minneapolis) [4]. The commercially available KSR 
medium is a serum-free formulation optimized for mouse ES cells. In some experiments, activin A-
induced EBs were grown in the presence of different concentrations of human recombinant TSH (hTSH, 
1–100 μU/ml; Fitzgerald Industries International, Inc., Concord, MA). For thyrocyte maturation, day 7 
EBs were harvested and dissociated to single cells and then re-plated in IMDM with 15% KSR and 
100 μU/ml hTSH in five different culture conditions for another 9 days: insulin (condition I); IGF-1 
(condition II); insulin and IGF-1 (condition III); 6H (six hormones: hydrocortisone, transferrin, glycyl-l-
histi-l-lysine acetate, somatostatin, TSH and insulin; condition IV); no treatment (condition V). Cells 
from re-plated cultures were harvested on days 11 and 16 for RT-PCR analysis and immunostaining.  
 
 
 
Fig. 1. The protocol for the generation of thyrocytes from ES cells. Undifferentiated mouse ES cells were cultured on irradiated 
mouse embryonic fibroblasts in IMDM containing LIF. To induce EB formation, ES cells were trypsinized into a single-cell 
suspension and were differentiated in EBDM for 2 days to form cellular aggregates. The differentiated cells were then further 
induced with 10 ng/ml activin A and TSH for 4 days in KSR medium. The EB-derived cells were further cultured for 5–10 days in 
the maturation medium containing TSH, insulin, and IGF-1. Abbreviation: LIF, leukemia inhibitory factor; TSH, thyroid stimulating 
hormone; IGF-1, insulin-growth factor-1; EBDM, embryoid body differentiation medium; KSR, knockout serum replacement 
medium. 
Gene expression analysis. For gene expression analysis, total RNA was isolated using an RNeasy kit 
(Qiagen, Valencia, CA) and was treated with ribonuclease-free deoxyribonuclease (Qiagen). Two 
micrograms of total RNA were reverse transcribed into cDNA using the Thermoscript First Strand 
Synthesis (Invitrogen). PCR was performed using standard protocols with 2.5 U platinum Taq 
polymerase (Invitrogen). The primers used in this study have been reported previously [2] and [4]. 
 
Flow cytometry. The cells were trypsinized and fixed with 2% paraformaldehyde in PBS for 15 min and 
permeabilized with 0.1% Triton X-100 in PBS. The resulting cells were incubated with rabbit anti-rat NIS 
(1:100) antibody (a gift from Dr. Nancy Carrasco, Albert Einstein College of Medicine, Bronx, NY), 
rabbit anti-human Tg (1:4000; DakoCytomation, Carpinteria, CA), or isotype-matched control antibody at 
room temperature for 30 min; washed with PBS; and stained with Alexa Fluro 594 chicken anti-rabbit 
IgG (1:2000; Molecular Probes, Eugene, OR) at room temperature for 30 min. The cells were then 
washed and re-suspended in PBS. Flow cytometric analysis was performed on a FACSCalibur flow 
cytometer (BD Biosciences). FACS data were generated using FlowJo software (FlowJo LLC, Ashland, 
OR). 
 
Immunostaining. Cells were fixed in 4% paraformaldehyde in PBS. After fixation, the cells were washed 
and permeabilized in PBS containing 0.1% Triton X-100 for 10 min, then pre-blocked with 3% BSA or 
5% normal rabbit serum for 1 h. The following primary antibodies were used: rabbit anti-rat NIS (1:100) 
and rabbit anti-human Tg (1:4000). For detection of primary antibodies, the cells were washed, and then 
incubated with Alexa Fluro 594 chicken anti-rabbit IgG (1:2000) for 30 min at room temperature. The 
stained cells were washed before mounting with 10 μl Vectashield mounting medium containing 4′,6-
diamidino-2-phenylindole (DAPI, Vector Laboratories, Burlingame, CA). Images were captured using an 
Axioskop fluorescent microscope (Carl Zeiss, Inc., Thornwood, NJ) at the Microscopy Shared Research 
Facility at Mount Sinai School of Medicine, New York, using Adobe Photoshop software (Adobe 
Systems, Inc., San Jose, CA).  
Statistical analysis. Numerical data are expressed as mean ± SEM. An unpaired, two-tailed t-test was 
used for comparison. P < 0.05 was considered significant. 
Results 
Derivation of thyrocyte progenitors from mouse ES cells by treatment with activin A and TSH 
To evaluate the thyrocyte differentiation potential of activin A-treated cell populations, undifferentiated 
TSHR+/− ES cells were cultured in suspension for 2 days with serum to induce EB differentiation. EBs 
were then transferred to serum-free cultures containing activin A for an additional 4 days. RT-PCR 
analyses revealed that 10 ng/ml of activin A increased the expression of endoderm-specific genes such as 
Sox17 and Foxa2. Foxa2 expression was initiated 4 days after the onset of differentiation, and its 
expression in concert with the initiation of Sox17 on day 4 is consistent with endoderm induction and 
specification ( Fig. 2A). As a comparison, we also examined differentiation during EB development by 
determining the expression of a mesoderm-specific gene, brachyury, a T-box domain-containing 
transcription factor. Brachyury expression was initiated 5 days after the onset of differentiation ( Fig. 2A), 
consistent with a previous report [5]. Molecular analysis of the stem cell marker Rex1, a zinc finger 
transcription factor found in ES cells but not in their differentiated progeny [10], showed that Rex1 was 
expressed between days 2 and 3 of differentiation and that its expression declined by day 6, also 
consistent with previous findings [10]. 
To determine whether thyrocyte progenitors were present in the differentiating cultures, we examined 
the temporal pattern of TSHR gene expression by RT-PCR. TSHR expression was initiated 4 days after 
the onset of differentiation, and was subsequently down-regulated to almost undetectable levels by day 6 ( 
Fig. 2A). Next, we used fluorescence-activated cell sorting (FACS) analysis to analyze the temporal 
patterns of GFP expression after in vitro differentiation of TSHR ES cells to explore whether GFP levels 
could be used to monitor TSHR expression. GFP expression was initiated 4 days after the onset of 
differentiation, and the population of cells expressing GFP was almost undetectable on day 6, consistent 
with the expression of TSHR gene. This suggests that GFP expression faithfully mimics endogenous 
TSHR expression in differentiating EBs, and confirmed that TSHR expression can be measured in this ES 
cell line by monitoring GFP expression with FACS analysis. These findings also indicate that, at the dose 
used, activin A can stimulate TSHR expression in EBs in the absence of serum. However, the reduction in 
the number of GFP-expressing cells in day 6 EBs suggests that potential of these cells to become 
thyrocytes is transient. 
We have previously reported that TSH is necessary to maintain TSHR gene expression during EB 
differentiation [2]. Given that the TSHR gene is transiently expressed in early EBs, we investigated the 
effects of TSH on the temporal expression of Foxa2, Sox17, and brachyury in activin A-induced 
endoderm and thyrocyte lineages in this ES cell model. As shown in Fig. 2C, the expression of these 
genes was not significantly affected by treatment with 1–100 μU/ml of TSH. The expression of TSHR and 
GFP genes was, however, extended from day 5 into day 6 EBs—a finding that was not seen with activin 
A treatment alone ( Fig. 2A and B). These data support the notion that TSH, directly or indirectly, 
stimulates a program of thyrocyte differentiation that is not induced at lower concentration of activin A. 
To further explore this observation, day 7 EBs were re-plated in a serum-free culture with TSH for an 
additional 10 days. Cells from these cultures were then stained with specific antibodies to two terminal 
thyrocyte differentiation markers, NIS and Tg, and analyzed via FACS. As shown in Fig. 2D, the number 
of NIS+ cells increased in EBs stimulated with TSH (26.5% ± 0.2% vs 16.6% ± 1.4%, TSH vs control, 
respectively) after 10 days of differentiation. In contrast, the numbers of Tg+ (4.8% ± 0.9% vs 
3.9% ± 0.2%; TSH vs control) or GFP+ (1.3% ± 0.1% vs 1.4% ± 0.3%, TSH vs control) cells were not 
significantly different. Moreover, NIS+, Tg+ or GFP+ cells were either undetectable or extremely rare in 
the cultures after 12 total days of differentiation. Together these observations suggest that although 
activin A and TSH can stimulate thyrocyte induction and specification, they are not sufficient to maintain 
the thyrocyte phenotype in the long run. We therefore set out to identify maturation factors that facilitate 
the terminal differentiation of thyrocytes in ES cell cultures. 
 
 
 
 
Fig. 2. Differentiation capacity of mouse TSHR+/− ES cells treated with activin A and TSH. (A) RT-PCR expression analysis of 
various markers characteristic of endoderm and mesoderm germ layers, including Foxa2, Sox17, and brachyury, in TSHR+/− EBs 
differentiated in serum-containing medium followed by serum-free medium supplemented with activin A. TSHR is a thyrocyte 
marker. Rex 1 is a stem cell marker. Numbers on top of the figure indicate days of differentiation. β-Actin serves as an internal 
control. Control experiments contained no reverse transcriptase (-RT). (B) Kinetics of GFP expression in early EBs. (C) RT-PCR 
analysis of gene expression profiles in activin A-treated EBs exposed to varying concentrations of TSH. (D) FACS analysis of GFP 
expression in EBs differentiated in serum-free medium supplemented with TSH (right panel). Control groups were not treated with 
TSH (left panel). (E) RT-PCR analysis of gene expression profiles in day 11 and day 16 EBs treated with different conditions. 
Abbreviations: I + I, insulin and IGF-1; 6H, 6 hormone medium; NT, no treatment (∗ indicates the band for Tg transcript). 
Insulin and IGF-1 are critical for thyrocyte maturation 
The growth factors insulin and IGF-1, in concert with TSH, are known to promote the proliferation of 
FRTL-5 cells, a line of rat thyrocytes [11] and [12]. Therefore, we transferred day 7 EBs co-stimulated 
with activin A and TSH to a serum-free medium containing TSH. We then added insulin and IGF-1 alone 
or in combination to the cultures in an attempt to induce the maturation of thyrocytes. Some cells were 
cultured in the presence of 6H medium, which promotes growth in FRTL-5 cells [13]. As shown in Fig. 
2E, the expression of NIS, TSHR, GFP, Foxa2, and Sox17 can be detected after a total of 11 days of 
differentiation. The expression levels were higher in insulin and IGF-1 treated groups. The expression of 
NIS, TSHR, GFP, Foxa2, and Sox17 was also found more intense in day 16 cultures. Furthermore, Tg 
expression was detected in day 16 cell cultures treated with insulin alone or with an insulin and IGF-1 
combination. However, we could not detect thyroperoxidase (TPO, the enzyme responsible for Tg 
iodination) expression in all samples. The addition of a 6H medium did not stimulate the expression of all 
thyroid genes examined in day 11 cultures, and with only a slight increase of the expression of NIS in the 
cultures found on day 16 cells ( Fig. 2E). 
Next, we analyzed the cell aggregates for the presence and location of TSHR (via GFP) and NIS. We 
stained these cells with anti-NIS antibody, followed by staining with Alexa Fluro 594 chicken anti-rabbit 
IgG and observation with fluorescent microscopy. We found that NIS was expressed at day 11 of 
differentiation ( Fig. 3). These data demonstrate that, at the dose used, insulin and IGF-1, either alone or 
in concert, can stimulate NIS and TSHR expression in EBs in a no-serum culture medium. The addition 
of 6H medium, however, did not enhance thyrocyte generation ( Fig. 3). Furthermore, as shown in Fig. 4, 
in many cell clusters, GFP (green) and NIS (red) were localized to either the cytoplasm (GFP) or the 
surface (NIS) of these cells, respectively, they also co-localized in some clusters (yellow). Because co-
expression of NIS and TSHR is a hallmark of thyrocytes, this observation suggests that these culture 
conditions can support the maturation of thyrocytes. Upon further differentiation (day 16) in the presence 
of insulin and IGF-1, the cells exhibit robust GFP expression and the cultures were strongly positive for 
NIS ( Fig. 4A). A significant up-regulation of Tg was also observed in many differentiated cells ( Fig. 
4B). Taken together, these observations suggest that addition of insulin and IGF-1 to late cultures enables 
the long-term propagation and differentiation of mature thyrocytes. 
 
 
 
 
 
 
Fig. 3. Characterization of thyrocytes derived from mouse ES cells. Two-color immunofluorescent analysis was performed on day 
11 of differentiation. Cells were stained with an antibody to NIS (red). TSHR expression is indicated by GFP (green). DAPI staining 
was used to identify the nucleus (blue). Note that immunofluorescence is not detected with the isotype control antibody. 
Abbreviations: I + I, insulin and IGF-1; 6H, 6 hormone medium. (For interpretation of the references to color in this figure legend, 
the reader is referred to the web version of this article.) 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 4. Further characterization of thyrocytes derived from mouse ES cells. (A) Microscopic analysis of cell aggregates derived from 
mouse TSHR+/− ES cells after 11 days of differentiation and stained with an antibody to NIS (red). TSHR expression is indicated by 
the GFP signal (green). An overlaid image shows the co-localization of NIS with TSHR (yellow). DAPI staining was used to 
identify the nucleus (blue). Note that high magnification demonstrates NIS expression in the plasma membrane. (B) 
Immunofluorescent images of several cell clusters derived from mouse ES cells after 16 days of differentiation. (For interpretation 
of the references to color in this figure legend, the reader is referred to the web version of this article.) 
Discussion 
We have previously shown that mouse ES cells can differentiate into thyrocyte-like cells if they are 
cultured during differentiation with TSH [2], [3] and [4]. This finding substantiates the severe congenital 
hypothyroidism that occurs in TSH- and TSHR-knockout mice [9] and [14]. Additional analyses of the 
expression of thyroid genes in differentiating ES cells suggest that the cells encompass the entire 
spectrum of thyroid development in vivo, offering an attractive model of otherwise inaccessible early 
embryonic events. Here we describe a new protocol for directing mouse ES cells to differentiate into 
mature thyrocytes within 16 days. This newly developed method is based on our previous studies, which 
demonstrated that TSH efficiently induces the differentiation of thyrocyte progenitors from mouse ES 
cells. However, this approach is not sufficient to induce the terminal differentiation of thyrocytes [4]. In 
the present study, we applied a combination of activin A, TSH, insulin and IGF-1, to differentiating ES 
cells in a step-wise approach. We clearly demonstrate through evaluation of the transcriptional status of 
known early-stage, thyroid-specific genes, FACS analysis and immunochemistry that mouse ES cells can 
differentiate into mature, Tg-expressing thyrocytes. 
A main goal of this work was to determine the molecular and cellular characteristics of thyrocyte-
fated populations derived from ES cells. In order to achieve this, it was crucial to devise a method to 
identify and monitor thyrocyte progenitors during differentiation. Although there is no single specific 
marker of a thyrocyte, a combination of specific markers can be used, including TSHR, NIS, and Tg. We 
found that a step-wise combination of activin A, TSH, insulin and IGF-1 enabled the differentiation of 
Tg-expressing thyrocyte populations. It is important to note that EB cell differentiation after day 2, activin 
A treatment and late thyrocyte differentiation were all carried out in the absence of serum. This probably 
contributed significantly to the high reproducibility of the terminal differentiation of thyrocyte cultures. 
Such a highly reliable and simple system will be essential for the development of therapeutic applications 
for human thyroid disease. 
In summary, the work describe here demonstrates for the first time that mouse ES cells can be induced 
by the presence of specific growth factors and signaling molecules to generate cell populations with 
characteristics similar to those of thyrocytes. Although many questions remain to be answered regarding 
the biochemical characteristics of these thyrocytes, this protocol represents an important step toward 
generating thyroid-hormone-producing cells from mouse ES cells. Our system will permit in vitro “gain-
of-function” or “loss-of-function” genetic studies that will help identify the genes downstream of TSHR 
that contribute to thyrocyte development. Studies of pluripotent ES cells will lead to in vitro models of 
thyroid development, which may ultimately provide new insights into the underlying causes of human 
thyroid disease. 
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